Nanoparticle Technologies in the Spinal Cord

Jonathan M. Zuidema, Ryan J. Gilbert, Donna J. Osterhout

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations

Abstract

Nanoparticles are increasingly being studied within experimental models of spinal cord injury (SCI). They are used to image cells and tissue, move cells to specific regions of the spinal cord, and deliver therapeutic agents locally. The focus of this article is to provide a brief overview of the different types of nanoparticles being studied for spinal cord applications and present data showing the capability of nanoparticles to deliver the chondroitinase ABC (chABC) enzyme locally following acute SCI in rats. Nanoparticles releasing chABC helped promote axonal regeneration following injury, and the nanoparticles also protected the enzyme from rapid degradation. In summary, nanoparticles are viable materials for diagnostic or therapeutic applications within experimental models of SCI and have potential for future clinical use.

Original languageEnglish
Pages (from-to)102-115
Number of pages14
JournalCells Tissues Organs
Volume202
Issue number1-2
DOIs
StatePublished - Oct 1 2016

Bibliographical note

Publisher Copyright:
© 2016 S. Karger AG, Basel. All rights reserved.

Keywords

  • Chondroitinase ABC
  • Drug delivery
  • Nanoparticle
  • Poly-L-lactic acid
  • Spinal cord injury

ASJC Scopus subject areas

  • Anatomy
  • Histology

Fingerprint

Dive into the research topics of 'Nanoparticle Technologies in the Spinal Cord'. Together they form a unique fingerprint.

Cite this